Elspar

Elspar information and resources from the National Cancer Institute

Elspar

(Other name for: asparaginase)Elspar

(Other name for: asparaginase)

Asparaginase

ELSPAR is indicated in the therapy of patients with acute lymphocytic leukemia. This agent is useful primarily in combination with other chemotherapeutic agents in the induction of remissions of the disease in pediatric patients.

Merck & Co, Inc Aug 01 2002

Cherokee operation to be sold by Merck Nov 30, 2005
Patriot-News, Humphrey said. The plant makes pharmaceutical ingredients for several antibiotics, including Invanz, Primaxin and Elspar. Ed Vallo ...

Enzon Files sBLA for First-Line Use of ONCASPAR(R); FDA Accepts ... Dec 1, 2005
Genetic Engineering News, CCG-1962 is a randomized controlled study comparing ONCASPAR versus native L-asparaginase (Elspar(R)) for the first-line treatment of pediatric ALL patients. ...

Elspar -->